Advisers to the FDA back Novavax COVID vaccine
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Stay updated with breaking news from Eric Rubin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax's Covid-19 vaccine -- which uses different technology from the three vaccines currently in use in the
Jon Cherry/Bloomberg via Getty Images, FILE(WASHINGTON) -- The Food and Drug Administration's independent panel of advisers has voted in favor of the FDA